Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-14 Purchase | 2026-01-16 4:02 pm | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 49,000 | $1.676 | $82,124 | 2,410,477 (Indirect Direct) | View |
| 2026-01-14 Purchase | 2026-01-16 4:01 pm | Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer | 8,832 | $1.6983 | $14,999 | 20,983 (Direct) | View |
| 2026-01-13 Purchase | 2026-01-15 4:38 pm | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 10,000 | $1.7218 | $17,218 | 75,308 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-01 Option Award | 2026-03-03 4:22 pm | N/A 2036-02-29 | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 31,900 | $0 | 31,900 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 4:21 pm | N/A 2036-02-29 | Acrivon Therapeutics Inc. | ACRV | Mirza Mansoor Raza Chief Medical Officer | 174,068 | $0 | 174,068 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 4:19 pm | N/A 2036-02-29 | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 129,760 | $0 | 129,760 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 4:19 pm | N/A 2036-02-29 | Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer | 132,925 | $0 | 132,925 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 4:17 pm | N/A 2036-02-29 | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 94,946 | $0 | 94,946 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 4:16 pm | N/A 2036-02-29 | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 186,728 | $0 | 186,728 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 4:15 pm | N/A 2036-02-29 | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 602,705 | $0 | 602,705 (Direct) | View |
| 2026-02-21 Tax Withholding | 2026-02-24 4:12 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 14,265 | $1.53 | 2,394,331 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-18 4:14 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 116 | $1.63 | 4,006 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-18 4:12 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 217 | $1.63 | 33,679 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-18 4:11 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 471 | $1.63 | 14,812 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-18 4:10 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 723 | $1.63 | 74,585 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-18 4:09 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 1,881 | $1.63 | 2,408,596 (Direct) | View |
| 2026-01-17 Tax Withholding | 2026-01-21 4:02 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 659 | $1.98 | 33,896 (Direct) | View |
| 2025-11-21 Tax Withholding | 2025-11-25 4:03 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 19,904 | $2.3 | 2,361,477 (Direct) | View |
| 2025-11-14 Tax Withholding | 2025-11-18 4:33 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $2.24 | 4,122 (Direct) | View |
| 2025-11-14 Tax Withholding | 2025-11-18 4:32 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 184 | $2.24 | 34,555 (Direct) | View |
| 2025-11-14 Tax Withholding | 2025-11-18 4:30 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 403 | $2.24 | 15,283 (Direct) | View |
| 2025-11-14 Tax Withholding | 2025-11-18 4:29 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 613 | $2.24 | 65,308 (Direct) | View |
| 2025-11-14 Tax Withholding | 2025-11-18 4:28 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 60,255 | $2.24 | 2,381,381 (Direct) | View |
| 2025-10-17 Tax Withholding | 2025-10-21 4:06 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 558 | $1.81 | 34,739 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:28 pm | N/A 2035-09-30 | Acrivon Therapeutics Inc. | ACRV | Mirza Mansoor Raza Chief Medical Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2025-10-01 Tax Withholding | 2025-10-03 4:26 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 284 | $1.81 | 35,297 (Direct) | View |
| 2025-08-21 Tax Withholding | 2025-08-25 4:39 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 19,905 | $1.32 | 2,441,636 (Direct) | View |
| 2025-08-14 Tax Withholding | 2025-08-18 5:19 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $1.39 | 4,221 (Direct) | View |
| 2025-08-14 Tax Withholding | 2025-08-18 5:18 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 184 | $1.39 | 35,581 (Direct) | View |
| 2025-08-14 Tax Withholding | 2025-08-18 5:16 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 403 | $1.39 | 15,686 (Direct) | View |
| 2025-08-14 Tax Withholding | 2025-08-18 5:15 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 613 | $1.39 | 65,921 (Direct) | View |
| 2025-08-14 Tax Withholding | 2025-08-18 5:14 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 60,256 | $1.39 | 2,461,541 (Direct) | View |
| 2025-08-01 Tax Withholding | 2025-08-05 4:59 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer | 1,164 | $1.26 | 12,151 (Direct) | View |
| 2025-07-17 Tax Withholding | 2025-07-21 4:28 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 558 | $1.32 | 35,765 (Direct) | View |
| 2025-06-13 Option Award | 2025-06-17 8:17 pm | N/A 2035-06-12 | Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 20,275 | $0 | 20,275 (Indirect) | View |
| 2025-06-13 Option Award | 2025-06-17 6:04 pm | N/A 2035-06-12 | Acrivon Therapeutics Inc. | ACRV | DiRocco Derek Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2025-06-13 Option Award | 2025-06-17 5:57 pm | N/A 2035-06-12 | Acrivon Therapeutics Inc. | ACRV | TOMSICEK MICHAEL JOHN Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2025-06-13 Option Award | 2025-06-17 5:54 pm | N/A 2035-06-12 | Acrivon Therapeutics Inc. | ACRV | Shacham Sharon Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2025-06-13 Option Award | 2025-06-17 5:49 pm | N/A 2035-06-12 | Acrivon Therapeutics Inc. | ACRV | Palani Santhosh Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2025-06-13 Option Award | 2025-06-17 5:48 pm | N/A 2035-06-12 | Acrivon Therapeutics Inc. | ACRV | Magovcevic-Liebisch Ivana Director | 20,275 | $0 | 20,275 (Direct) | View |